PMID: 25752725
Question: Schizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 25752725
Question: Schizophrenia patients with high intelligence: A clinically distinct sub-type of schizophrenia?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content Understanding:** The research question seeks to determine whether schizophrenia patients with high intelligence represent a clinically distinct subtype of schizophrenia.
- **Key Information to Identify:** Differences in symptom profiles, cognitive functioning, and clinical outcomes between high-IQ schizophrenia patients and those with typical IQ levels.

**2. Evidence Evaluation**
- **Research Results and Data:** The study identified 29 schizophrenia patients with exceptionally high pre-morbid IQ (mean IQ of 120). These patients exhibited significantly lower negative and disorganized symptoms, better global functioning, and greater insight compared to a control group with typical IQ levels. Additionally, those with minimal post-onset IQ decline showed higher levels of manic symptoms.
- **Strength and Reliability of Evidence:** The study employs multinomial logistic regression and provides statistically significant results (p-values < 0.05) with confidence intervals, indicating reliable findings despite the relatively small sample size.
- **Relevance to the Question:** The findings directly address the distinctions in clinical presentations between high-IQ and typical-IQ schizophrenia patients, supporting the existence of a unique subtype.

**3. Conclusion**
Based on the study's findings, there is substantial evidence to suggest that schizophrenia patients with high intelligence exhibit distinct clinical features compared to those with typical IQ levels. This supports the notion of a separate subtype within the schizophrenia spectrum.

**4. Final Answer**
**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether schizophrenia patients with high pre-morbid intelligence represent a clinically distinct subtype of schizophrenia. Key information to evaluate includes differences in symptom profiles, functional outcomes, and statistical significance of results compared to typical schizophrenia patients.  

**2. Evidence Evaluation**  
- **Symptom Differences**: High-IQ patients had significantly lower scores on negative and disorganized symptoms (RRR=0.019, P=0.030) and higher manic symptoms if they had minimal IQ decline (RRR=8.213, P=0.046).  
- **Functional Outcomes**: They showed better global functioning and insight (RRR=1.082, P=0.009).  
- **Statistical Strength**: The p-values for negative/disorganized symptoms and functioning were marginally significant (P=0.030 and P=0.009, respectively), while the manic symptom result had a wider confidence interval (CI=1.042–64.750).  
- **Sample Size**: The study included only 29 high-IQ patients, which is small but sufficient to detect significant trends.  
- **Relevance**: The findings directly address symptom and functional differences, supporting the idea of a distinct subgroup aligned with a "psychosis spectrum" concept.  

**3. Conclusion**  
The evidence suggests that high-IQ schizophrenia patients exhibit clinically meaningful differences in symptom profiles (fewer negative/disorganized symptoms, more manic symptoms in some) and better functional outcomes compared to typical schizophrenia patients. While the sample size is limited and some results have wide confidence intervals, the abstract’s conclusion explicitly endorses the existence of a distinct high-IQ variant. This supports answering "yes."  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether schizophrenia patients with high pre-morbid intelligence represent a clinically distinct sub-type. Key points to evaluate include symptom profile differences (e.g., negative/disorganized symptoms, functioning, insight) between high-IQ and typical-IQ patients and whether these differences are statistically and clinically meaningful.

**2. Evidence Evaluation**  
The study found:  
- High-IQ patients had **significantly lower negative/disorganized symptoms** (RRR=0.019, *P=0.030*), **better global functioning**, and **better insight** (RRR=1.082, *P=0.009*) compared to typical-IQ patients.  
- Minimal IQ decline post-onset correlated with **higher manic symptoms** (RRR=8.213, *P=0.046*).  
- Results are statistically significant (narrow confidence intervals, *P*-values <0.05), and the authors conclude this supports a "high-IQ variant" with distinct features.  
- Limitations include a small sample size (*n=29*) and reliance on estimated pre-morbid IQ.  

**3. Conclusion**  
The evidence shows meaningful symptom and functional differences, suggesting a distinct clinical profile. However, "sub-type" implies categorical differentiation, while the study emphasizes a "psychosis spectrum." The findings strongly support differences but leave some uncertainty about rigid sub-type classification.  

**4. Final Answer**  
**My final choice is: "yes"**
DeepSeek selected: yes

Initial consensus: All models selected yes